Aviva’s Haemonetics HAE Stock Holding History

Aviva’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,334	Closed	-$1.15M	–	914
2021 Q1	$1.15M	Sell	10,334 -4,570	-31%	-$566K	0.01%	891
2020 Q4	$1.77M	Sell	14,904 -12,085	-45%	-$1.3M	0.01%	706
2020 Q3	$2.35M	Buy	26,989 +1,034	+4%	+$90.4K	0.01%	643
2020 Q2	$2.33M	Sell	25,955 -9,446	-27%	-$954K	0.01%	656
2020 Q1	$3.53M	Buy	35,401 +19,648	+125%	+$2.13M	0.03%	606
2019 Q4	$1.81M	Buy	+15,753	New	+$1.91M	0.01%	821

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Aviva's HAE Position: Q2 2021 in Review

Aviva sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 10,334 shares — an estimated $1.15M sold.

Aviva first reported a position in HAE in Q4 2019 and held it in 6 quarters. The position peaked at $3.53M in Q1 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

Aviva reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
Aviva sold 10,334 Haemonetics shares in Q2 2021, an estimated $1.15M.
Aviva first reported a position in Haemonetics in Q4 2019 and held it in 6 quarters.
Aviva's Haemonetics position peaked at $3.53M in Q1 2020.
258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.